Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
12.88
+0.15 (1.18%)
Feb 24, 2026, 4:00 PM EST - Market closed
Tango Therapeutics Market Cap
Tango Therapeutics has a market cap or net worth of $1.73 billion as of February 24, 2026. Its market cap has increased by 395.35% in one year.
Market Cap
1.73B
Enterprise Value
1.61B
1-Year Change
395.35%
Ranking
Category
Stock Price
$12.88
Market Cap Chart
Since April 20, 2021, Tango Therapeutics's market cap has increased from $156.31M to $1.73B, an increase of 1,009.77%. That is a compound annual growth rate of 64.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 23, 2026 | 1.71B | 43.68% |
| Dec 31, 2025 | 1.19B | 259.49% |
| Dec 31, 2024 | 331.92M | -67.13% |
| Dec 29, 2023 | 1.01B | 57.94% |
| Dec 30, 2022 | 639.29M | -33.25% |
| Dec 31, 2021 | 957.76M | 512.74% |
| Apr 20, 2021 | 156.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharvaris | 1.78B |
| Tyra Biosciences | 1.77B |
| Recursion Pharmaceuticals | 1.76B |
| Agios Pharmaceuticals | 1.75B |
| Innoviva | 1.74B |
| Syndax Pharmaceuticals | 1.72B |
| MannKind | 1.70B |
| Zymeworks | 1.70B |